Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 27.37 |
| Open | 27.68 |
| Bid | 27.40 x 0 |
| Ask | 27.60 x 0 |
| Day's Range | 27.47 - 27.70 |
| 52 Week Range | 18.10 - 30.08 |
| Volume | 459,777 |
| Avg. Volume | 779,823 |
| Market Cap | 39.89B |
| Beta (5Y Monthly) | 0.28 |
| PE Ratio (TTM) | 59.00 |
| EPS (TTM) | 0.47 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.21 (0.75%) |
| Ex-Dividend Date | Nov 11, 2020 |
| 1y Target Est | 12.43 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Simply Wall St.
Is ResMed Inc. (NYSE:RMD) Popular Amongst Institutions?
Every investor in ResMed Inc. ( NYSE:RMD ) should be aware of the most powerful shareholder groups. Large companies...
- Zacks
QDEL vs. RMD: Which Stock Is the Better Value Option?
QDEL vs. RMD: Which Stock Is the Better Value Option?
- Business Wire
ResMed to Report Second Quarter Fiscal 2021 Earnings on January 28, 2021
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2021 on Thursday, January 28, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
© 2021 Verizon Media. All rights reserved.
